Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Depakote Stories

2011-06-11 00:00:30

A new study published by has indicated that infants exposed to antiepileptic drugs, such as Depakote, during pregnancy may have an even higher risk of developing serious birth defects. However, taking lower doses of Depakote may carry similar risks as higher doses of "safer" antiepileptics. Antiepileptic drugs are commonly prescribed to women suffering from epilepsy and seizure-related disorders, as well as bipolar disorder. The Consumer Justice Foundation has provided more information...

2011-04-28 00:00:29

The law firm of Atkins & Markoff, a team of Oklahoma defective drug attorneys, hereby announces that the firm is reviewing claims free of charge regarding Depakote birth defects along with a full Depakote resource at http://www.atkinsandmarkoff.com. Depakote is an anticonvulsant or antiepileptic drug that has recently been found to lead to birth defetcs when used during pregnancy. Oklahoma City, OK (PRWEB) April 27, 2011 The Oklahoma law firm of Atkins & Markoff hereby announces...

2011-04-15 00:00:30

Anticonvulsant medications such as Depakote are being found to possibly cause birth defects according to recent studies. Victims of these anticonvulsant birth defects may need financial help to provide potential life-long medical care for children born with such conditions as spina bifida, heart malformations, or physical cleft injuries. More information about this can be found at http://www.consumerjusticefoundation.com. (Vocus/PRWEB) April 14, 2011 The Consumer Justice Foundation (CJF)...

2011-04-15 00:00:30

Researchers at the University of Groningen, in the Netherlands, have uncovered that exposure to Valproic acid in fetuses can lead to severe birth defects. Valproic acid is a common ingredient in anticonvulsant drugs such as Depakote. Additional resources can be found at http://www.depakotebirthinjury.com. (Vocus/PRWEB) April 14, 2011 The Consumer Justice Foundation works diligently to inform American consumers about potentially dangerous pharmaceuticals and other harmful substances offered...

2011-04-12 00:00:30

As more victims of Depakote use during pregnancy speak out about the birth defects that have affected the lives of their families, Depakote attorneys working with the Consumer Justice Foundation website http://www.depakotebirthinjury.com are trying to recoup compensation for the life long medical care that will be required to treat children born with skeletal defects. The Consumer Justice Foundation is a resource for the American people who have been adversely affected by corporate entities...

2011-03-28 00:00:27

As lawsuits against the makers of the epilepsy drug Depakote begin to surface in the United States, Depakote lawyers begin to consult with families of birth defect victims about possible Depakote lawsuits. Depakote is a prescription anticonvulsant used to treat epilepsy and the manic phase of bipolar disorder. Depakote Birth Injury Resources provides online information about possible Depakote birth defects and means to connect with Depakote lawyers. (PRWEB) March 26, 2011 As new studies...

2011-01-09 00:43:14

The prescription drug Depakote is currently the most prescribed branded treatment for patients with mania associated with bipolar disorder as well as for the treatment of epilepsy. Depakote is produced by Abbott Laboratories, a pharmaceutical company based in Abbott Park, North Chicago, Illinois. Currently, Abbot Laboratories is being evaluated by Depakote Birth Injury Resources ("DBIR" or DepakoteBirthInjury.com) for the high number of birth defects and birth injuries resulting from the...

2010-12-05 00:13:28

The US Food and Drug Administration has issued a warning to health care professionals and patients about the potential increased risk of birth injuries and birth defects when valproate sodium and related products (e.g. Depacon, Depakote or Stavzor) are used by mothers during pregnancy. Depakote Birth Injury Resources (DepakoteBirthInjury.com) offers information and resources about the possible side effects of valproate sodium, including neural tube malformations, craniofacial defects and...

2010-01-27 06:46:00

ABBOTT PARK, Ill., Jan. 27 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2009. Diluted earnings per share, excluding specified items, were $1.18, reflecting 11.3 percent growth, at the high end of Abbott's previous forecast. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.98, up 10.1 percent. Worldwide sales increased 10.6 percent to nearly $8.8 billion, including a...

2009-10-14 06:47:00

ABBOTT PARK, Ill., Oct. 14 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2009. Diluted earnings per share, excluding specified items, were $0.92, above Abbott's guidance range of $0.88 to $0.90. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.95. The company is raising its ongoing earnings outlook for 2009 to $3.70 to $3.72, above its previous range of $3.65 to...